tirzepatide approved for weight loss Tirzepatide Unlikely to Exacerbate DR

Metabolism : People with a faster metabolism will break down Mounjaro quicker than those with slower metabolisms

Tirzepatide is a GLP1 (Glucagon-like peptide-1) + GIP (glucose-dependent insulinotropic polypeptide) receptor agonist combination drug that has been approved by India's CDSCO (Central Drugs Standard Control Organisation) for patients of type 2 diabetes mellitus (T2DM) and obesity

When determining the optimal timing for your next in-person or telehealth appointment, a four-week interval is recommended to coincide with your unique treatment plan and progress

What is the main difference between how oral and injectable semaglutide are absorbed

A consultation with a healthcare professional, like a Midi clinician, can help you find the perfect combination to get your groove back

August 2025 : Eli Lilly asked the court to consolidate vision loss lawsuits into a new, separate multidistrict litigation to be heard by the same judge already overseeing the existing GLP-1 MDL